Karpus Investment Management’s Apexigen, Inc. Common Stock APGN Stock Holding History

Karpus Investment Management’s Portfolio APGN Stock Details APGN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q3	–	Sell	-365,868	Closed	-$3.72M	–	536
2022 Q2	$3.72M	Sell	365,868 -2,148	-0.6%	-$21.7K	0.13%	173
2022 Q1	$3.71M	Buy	368,016 +3,957	+1%	+$39.7K	0.11%	180
2021 Q4	$3.64M	Buy	364,059 +120,636	+50%	+$1.2M	0.1%	178
2021 Q3	$2.42M	Buy	243,423 +38,300	+19%	+$379K	0.07%	165
2021 Q2	$2.04M	Buy	205,123 +74,881	+57%	+$742K	0.06%	179
2021 Q1	$1.28M	Buy	+130,242	New	+$1.3M	0.04%	194

Other funds holding APGN

DCMIC

Decheng Capital Management III (Cayman) Grand Cayman, Cayman Islands $300M AUM 15.74% 1-Year Est. Return

Yu Fan $108M AUM 137.54% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Citadel Advisors Miami, Florida $875B AUM 40.91% 1-Year Est. Return

Jane Street New York $1.21T AUM 78.12% 1-Year Est. Return

Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return

Two Sigma Investments New York $138B AUM 41.87% 1-Year Est. Return

Karpus Investment Management's APGN Position: Q3 2022 in Review

Karpus Investment Management sold out of Apexigen, Inc. Common Stock (APGN) in Q3 2022, closing a stake of 365,868 shares — an estimated $3.72M sold.

Karpus Investment Management first reported a position in APGN in Q1 2021 and held it in 6 quarters. The position peaked at $3.72M in Q2 2022. 18 funds tracked by Wall St. Rank hold APGN as of Q3 2022.

Karpus Investment Management reported no remaining Apexigen, Inc. Common Stock position as of Q3 2022 after selling out during the quarter.
Karpus Investment Management sold 365,868 Apexigen, Inc. Common Stock shares in Q3 2022, an estimated $3.72M.
Karpus Investment Management first reported a position in Apexigen, Inc. Common Stock in Q1 2021 and held it in 6 quarters.
Karpus Investment Management's Apexigen, Inc. Common Stock position peaked at $3.72M in Q2 2022.
18 funds tracked by Wall St. Rank held Apexigen, Inc. Common Stock as of Q3 2022.

Based on Karpus Investment Management's 13F filing for Q3 2022, filed 14 Nov 2022.